Rocket Lab Corporation enters the post-earnings week with a new dynamic: short sellers backed off after the print, yet the stock at $80 still hasn't cleared the range where its own CEO was selling a month ago.
The clearest shift this week is in short positioning. Short interest fell to 8.8% of the free float on August 11 — down 3.4% in a single session and 2% on the week. That marks the first meaningful pullback after a month-long build that had pushed SI up 13% since mid-July. The retreat suggests some shorts covered into the earnings reaction, which saw the stock fall just 3.4% the following day — a contained move that didn't reward the more aggressive positioning built ahead of the print. Borrow conditions reinforce the absence of real squeeze pressure: availability is running at 282%, meaning nearly three shares are available to borrow for every one already shorted, and cost to borrow has eased to 0.43% — down 11% on the week and close to a 30-day low. The lending market is loose; this is a manageable short, not a crowded one.
Options sentiment is broadly neutral. The put/call ratio is 0.70, sitting barely a third of a standard deviation above its 20-day average of 0.69. There is no defensive spike, no unusual demand for downside protection. The 52-week range for the PCR runs from 0.36 to 0.85, placing today's reading well within normal territory. Options traders are not bracing for anything in particular.
The insider picture has not changed since July 8, and that remains the central tension. CEO Peter Beck sold more than 1.6 million shares at $81–$89 across July 7–8, generating roughly $145 million in proceeds. Net insider activity over the trailing 90 days totals approximately $302 million in sales with no offsetting purchases. The stock closed Tuesday at $80.01 — within the lower bound of Beck's selling range but not yet through it. Prior notes in this series have consistently flagged this as the sharpest signal in the name. Nothing in this week's data alters that read: Beck's selling prices form a natural ceiling that the market has not yet reclaimed. Whether that reflects a calculated view of fair value or routine diversification, the arithmetic is visible to every holder.
Institutional ownership is orderly rather than concentrated. BlackRock added 2.6 million shares in the most recent reporting period to hold 6.8% of shares. Vanguard entities collectively own roughly 9% across two funds. The holder count of 268 institutions is not thin, but there are no obvious swing-factor names moving aggressively in either direction. Peer momentum has been strong this week — RDW gained 27%, VOYG rose 28%, and LUNR added 18% — all outpacing RKLB's 7.4% weekly gain, which suggests the broader space cohort caught a stronger bid than this name specifically.
Valuation remains a friction point for new money. The EV/EBITDA multiple is running near 1,100x on trailing figures, and the trailing P/E is effectively unmeasurable given near-zero earnings. The stock scores in the 14th percentile on short score rank — meaning most of the universe carries heavier short positioning — while EPS momentum over both 30-day and 90-day windows sits in the 2nd percentile, indicating estimates have been drifting lower. The EPS surprise score is a notable exception at the 89th percentile, suggesting the company has repeatedly beaten depressed consensus expectations. That beat-on-low-bar dynamic likely explains the earnings bounce more than any fundamental re-rating.
The next test is whether RKLB can sustain a close above $81 — the lower end of Beck's July selling range — and whether the short interest retreat continues or reverses as the post-earnings dust settles.
See the live data behind this article on ORTEX.
Open RKLB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
